Six Clocks, Forty-Two Patients, and the Question Nobody Can Answer Yet
By Ervin Dhima
An AI-designed lung drug made six independent aging clocks run backward. But the study was a retrospective read of banked blood from 42 terminally ill patients, and the Phase III trial now running has no aging endpoint at all. What the rentosertib result actually shows.